Mechanisms of Cardiorenal Protection of Glucagon-Like Peptide-1 Receptor Agonists
{{output}}
The worldwide prevalence of type 2 diabetes (T2D) is steadily increasing, and it remains a challenging public health problem for populations in both developing and developed countries around the world. Despite the recent advances in novel antidiabetic agents, ... ...